UCBJF News and Press, UCB SA From 04/09/25

2025-04-09 06:02:04 ET More on European drugmakers Novartis After Sandoz: The Business Without Generics AstraZeneca's Innovation Ecosystem: From Blockbusters To The Next Generation Of Therapy Novo Nordisk: Not As Bullish As Many Daiichi Sankyo and AstraZeneca...

2025-03-18 11:18:34 ET More on MoonLake Immunotherapeutics MoonLake Immunotherapeutics: Mid-2025 Sonelokimab HS Data Could Be Enhanced Upon MoonLake Immunotherapeutics reports Q4 results MoonLake upgraded at Goldman Sachs on promise of hidradenitis suppurativa asset ...

2025-02-09 09:36:00 ET Summary Fidelity® International Discovery Fund is a diversified international equity strategy that seeks capital growth by investing primarily in non-U.S. stocks. For the final quarter of 2024, the fund's Retail Class shares returned -6.19%, outpac...

2025-01-30 09:15:00 ET Summary International equities continued to struggle in the fourth quarter due to market concerns about tariff wars and potentially other punitive measures that could be levied by the second Trump administration. The benchmark MSCI EAFE Index declined 8.11% ...

2025-01-10 04:10:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...